文献速递关节外科

接受择期全关节置换术的丙型肝炎患者治疗与结局的种族差异

Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2024-02-06

该研究比较接受择期全髋关节置换术(THA)和全膝关节置换术(TKA)的黑人与白人丙型肝炎病毒(HCV)感染患者,发现黑人患者术前肝功能指标更高、更少接受HCV治疗、术前病毒载量阳性率更高且住院时间更长;术前HCV治疗并达到病毒载量检测不到是减少术后并发症(包括关节感染)的关键因素。

要点

  • 黑人THA患者术前未接受HCV治疗的比例为65.8%,白人为35.6%(P=0.002);TKA为72.1% vs 37.3%(P=0.009)。
  • 黑人THA患者术前病毒载量阳性率为66% vs 白人38%(P=0.006);TKA为72% vs 37%(P<0.001)。
  • 黑人患者住院时间更长:THA为3.7 vs 3.3(P=0.008);TKA为4.1 vs 3.0(P=0.02)。

核心结论

  • 术前接受HCV治疗并达到病毒载量检测不到是减少THA和TKA术后并发症(包括关节感染)的关键因素。
  • 黑人患者更可能未接受HCV治疗即接受关节置换术且术前病毒载量阳性;尽管两种族病毒载量阳性率随时间下降,黑人患者的差距持续存在。

研究设计与样本

  • 研究比较接受择期THA和TKA的黑人与白人HCV感染患者,收集人口学、合并症、HCV特征、围手术期变量、院内结局及术后1年随访并发症。
  • 识别术前病毒载量阳性(PVL)和病毒载量检测不到的患者;分类变量采用卡方检验和Fisher精确检验,连续变量采用双尾Student's Kruskal-Wallis t检验,P<0.05为有统计学意义。

主要发现

  • 黑人THA患者术前天冬氨酸氨基转移酶(P=0.01)和终末期肝病模型评分(P<0.001)均高于白人;TKA患者分别为P=0.03和P=0.003。
  • 黑人患者更可能未接受HCV治疗即接受THA(65.8% vs 35.6%,P=0.002)和TKA(72.1% vs 37.3%,P=0.009)。
  • 黑人患者术前PVL率更高:THA为66% vs 38%(P=0.006);TKA为72% vs 37%(P<0.001)。
  • 黑人患者住院时间更长:THA为3.7 vs 3.3(P=0.008);TKA为4.1 vs 3.0(P=0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: African Americans have the highest prevalence of chronic Hepatitis C virus (HCV) infection. Racial disparities in outcome are observed after elective total hip arthroplasty (THA) and total knee arthroplasty (TKA). This study sought to identify if disparities in treatments and outcomes exist between Black and White patients who have HCV prior to elective THA and TKA. METHODS: Patient demographics, comorbidities, HCV characteristics, perioperative variables, in-hospital outcomes, and postoperative complications at 1-year follow-up were collected and compared between the 2 races. Patients who have preoperative positive viral load (PVL) and undetectable viral load were identified. Chi-square and Fisher's exact tests were used to compare categorical variables, while 2-tailed Student's Kruskal-Wallis t-tests were used for continuous variables. A P value of less than .05 was statistically significant. RESULTS: The liver function parameters, including aspartate aminotransferase and model for end-stage liver disease scores, were all higher preoperatively in Black patients undergoing THA (P = .01; P < .001) and TKA (P = .03; P = .003), respectively. Black patients were more likely to undergo THA (65.8% versus 35.6%; P = .002) and TKA (72.1% versus 37.3%; 0.009) without receiving prior treatment for HCV. Consequently, Black patients had higher rates of preoperative PVL compared to White patients in both THA (66% versus 38%, P = .006) and TKA (72% versus 37%, P < .001) groups. Black patients had a longer length of stay for both THA (3.7 versus 3.3; P = .008) and TKA (4.1 versus 3.0; P = .02). CONCLUSIONS: The HCV treatment prior to THA and TKA with undetectable viral load has been shown to be a key factor in mitigating postoperative complications, including joint infection. We noted that Black patients were more likely to undergo joint arthroplasty who did not receive treatment and with a PVL. While PVL rates decreased over time for both races, a significant gap persists for Black patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Howie CM, Cichos KH, Shoreibah MG, et al. Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty. J Arthroplasty. 2024. PMID: 38331360. doi:10.1016/j.arth.2024.01.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。